Milton Packer, MD; W. Mark Armstrong, MD; Joseph M. Rothstein, MD; Michael Emmett, MD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1932.
Requests for Single Reprints: Milton Packer, MD, Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, TX 75226; e-mail, email@example.com.
Current Author Addresses: Dr. Packer: Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, TX 75226.
Drs. Armstrong, Rothstein, and Emmett: Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246.
Packer M, Armstrong WM, Rothstein JM, et al. Sacubitril–Valsartan in Heart Failure: Why Are More Physicians Not Prescribing It?. Ann Intern Med. 2016;165:735–736. [Epub ahead of print 30 August 2016]. doi: https://doi.org/10.7326/M16-1932
Download citation file:
Published: Ann Intern Med. 2016;165(10):735-736.
Published at www.annals.org on 30 August 2016
Cardiology, Coronary Risk Factors, Heart Failure, Hypertension, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use